Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.35 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7105311 | 0.89 | CHRNB2 (0.39) | CHRNB2CHRNA4 | |
| SCHEMBL7103400 | 0.86 | CHRNB2 (0.35) | CHRNB2CHRNA4TRPV6 | |
| SCHEMBL7487692 | 0.85 | PROKR1 (0.35) | CHRNB2CHRNA4KDM4EGLAHTT | |
| SCHEMBL7485261 | 0.85 | PROKR1 (0.35) | CHRNB2CHRNA4KDM4EGLAHTT | |
| SCHEMBL7098460 | 0.83 | CHRNB2 (0.42) | CHRNB2CHRNA4 | |
| SCHEMBL7097525 | 0.83 | CHRNB2 (0.42) | CHRNB2CHRNA4 | |
| SCHEMBL7098381 | 0.78 | ALDH1A1 (0.39) | CHRNB2CHRNA4HTTKMT2A | |
| SCHEMBL7098852 | 0.78 | ALDH1A1 (0.39) | CHRNB2CHRNA4HTTKMT2A | |
| SCHEMBL7101259 | 0.77 | CHRNB2 (0.35) | CHRNB2CHRNA4 | |
| SCHEMBL7103819 | 0.77 | CHRNB2 (0.35) | CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1178982-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000071534-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2000-11-30 | — | — | WO | disclosed |